Minghetti P - Search Results

1

Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future?

Cagnazzo C, Besse MG, Manfellotto D, Minghetti P, Cazzaniga S, Cottini L, Fontanella A, Maruti I, Stabile S, Testoni S, Trogu P, Sinno V, Gussoni G. Cagnazzo C, et al. Among authors: minghetti p. Tumori. 2021 Feb;107(1):6-11. doi: 10.1177/0300891620977916. Epub 2020 Dec 9. Tumori. 2021. PMID: 33297885 Free PMC article.

2

Risk management of in-hospital administration of anticancer drugs: impact of Raccomandazione 14 from the Italian Ministry of Health.

Casiraghi A, Franzè S, Rocco P, Minghetti P. Casiraghi A, et al. Among authors: minghetti p. Tumori. 2016;102(Suppl 1):2-6. doi: 10.5301/tj.5000538. Epub 2016 Aug 29. Tumori. 2016. PMID: 27581594

3

The situation of OTC drugs in italy compared to the other EU states.

Minghetti P, Casiraghi A, Cilurzo F, Montanari L. Minghetti P, et al. Pharmacol Res. 2000 Jul;42(1):25-31. doi: 10.1006/phrs.1999.0643. Pharmacol Res. 2000. PMID: 10860631

4

Trends in opioid analgesics sales to community pharmacies and hospitals in Italy (2000-2010).

Caraceni AT, Brunelli C, Rocco P, Minghetti P. Caraceni AT, et al. Among authors: minghetti p. Minerva Anestesiol. 2013 Aug;79(8):906-14. Epub 2013 Apr 5. Minerva Anestesiol. 2013. PMID: 23558762

5

Dermal patches for the controlled release of miconazole: influence of the drug concentration on the technological characteristics.

Minghetti P, Cilurzo F, Casiraghi A, Molla FA, Montanari L. Minghetti P, et al. Drug Dev Ind Pharm. 1999 May;25(5):679-84. doi: 10.1081/ddc-100102225. Drug Dev Ind Pharm. 1999. PMID: 10219539

6

Application of viscometry and solubility parameters in miconazole patches development.

Minghetti P, Cilurzo F, Casiraghi A, Montanari L. Minghetti P, et al. Int J Pharm. 1999 Nov 10;190(1):91-101. doi: 10.1016/s0378-5173(99)00282-3. Int J Pharm. 1999. PMID: 10528101

7

Development of local patches containing melilot extract and ex vivo-in vivo evaluation of skin permeation.

Minghetti P, Casiraghi A, Cilurzo F, Montanari L. Minghetti P, et al. Eur J Pharm Sci. 2000 Apr;10(2):111-7. doi: 10.1016/s0928-0987(99)00094-9. Eur J Pharm Sci. 2000. PMID: 10727876 Clinical Trial.

8

Solvation enthalpies as descriptors of structure--in vitro percutaneous permeation relationship of benzoxazinones regioisomers.

Minghetti P, Casiraghi A, Cilurzo F, Montanari L, Monzani MV, Bertolini G, Zaliani A. Minghetti P, et al. Farmaco. 2000 Aug;55(8):563-8. doi: 10.1016/s0014-827x(00)00048-3. Farmaco. 2000. PMID: 11132734

9

Development of patches for the controlled release of dehydroepiandrosterone.

Minghetti P, Cilurzo F, Casiraghi A, Montanari L, Santoro A. Minghetti P, et al. Drug Dev Ind Pharm. 2001 Aug;27(7):711-7. doi: 10.1081/ddc-100107328. Drug Dev Ind Pharm. 2001. PMID: 11694019

10

Occlusive properties of monolayer patches: in vitro and in vivo evaluation.

Casiraghi A, Minghetti P, Cilurzo F, Montanari L, Naik A. Casiraghi A, et al. Among authors: minghetti p. Pharm Res. 2002 Apr;19(4):423-6. doi: 10.1023/a:1015179209091. Pharm Res. 2002. PMID: 12033374

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters